International Merchant Advisors Announces New CEO
Marketwire “Press Releases “
NASHVILLE, TN — (MARKET WIRE) — 10/22/10 — International Merchant Advisors, Inc. (PINKSHEETS: IMAI) has announced that Gordon Getz has joined IMAI’s board of directors and has been named Chief Executive Officer with immediate effect.
This signals the end of Seth Maling’s tenure as CEO and he will return to his former role as Director of Business Development. He said he “couldn’t be more pleased with the board’s choice” in a company statement.
Gordon Getz began his career as a pharmaceutical research biologist with Sterling Winthrop Research Institute in Renssalaer, NY and also has over 35 years of experience in sales and marketing in the pharmaceutical and specialty medical device sector of the healthcare industry including Pfizer Pharmaceuticals and Bristol Laboratories . Commenting on his appointment, Mr. Getz said, “I am extremely honored to take on the role of CEO of International Merchant Advisors . I look forward to working closely with other executives within the medical industry particularly the medical marijuana sector. I will strive to pick-up the pieces and move forward with new ideas and leadership to grow the Company and increase shareholder value.”